WIC
IPXL

Water Island Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Water Island Capital’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-190,000
Closed -$3.86M – 125
2017
Q3 		$3.86M Buy
+190,000
New +$3.63M 0.18% 64

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Water Island Capital's IPXL Position: Q4 2017 in Review

Water Island Capital sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 190,000 shares — an estimated $3.86M sold.

Water Island Capital first reported a position in IPXL in Q3 2017 and held it in 1 quarter. The position peaked at $3.86M in Q3 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Water Island Capital reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Water Island Capital sold 190,000 Impax Laboratories, Inc. shares in Q4 2017, an estimated $3.86M.
  • Water Island Capital first reported a position in Impax Laboratories, Inc. in Q3 2017 and held it in 1 quarter.
  • Water Island Capital's Impax Laboratories, Inc. position peaked at $3.86M in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Water Island Capital's 13F filing for Q4 2017, filed 13 Feb 2018.